Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy ; volume:14 ; number:1 ; day:30 ; month:7 ; year:2024 ; pages:1-16 ; date:12.2024
Scientific reports ; 14, Heft 1 (30.7.2024), 1-16, 12.2024
- Creator
-
Sidorenko, Valeria
Scodeller, Pablo
Uustare, Ain
Ogibalov, Ivan
Tasa, Andrus
Tshubrik, Olga
Salumäe, Liis
Sugahara, Kazuki N.
Simón-Gracia, Lorena
Teesalu, Tambet
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-64610-7
- URN
-
urn:nbn:de:101:1-2410230903006.245378713167
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sidorenko, Valeria
- Scodeller, Pablo
- Uustare, Ain
- Ogibalov, Ivan
- Tasa, Andrus
- Tshubrik, Olga
- Salumäe, Liis
- Sugahara, Kazuki N.
- Simón-Gracia, Lorena
- Teesalu, Tambet
- SpringerLink (Online service)
Other Objects (12)
Vascular wall microenvironment: exosomes secreted by adventitial fibroblasts induced vascular calcification
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism
Three-dimensional vascular microenvironment landscape in human glioblastoma
Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Disrupting concrete construction
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Vascular promotion reprograms the tumour microenvironment toward enhanced drug delivery
Vascular normalization: a strategy to recondition the tumor immune microenvironment
Vascular wall microenvironment: exosomes secreted by adventitial fibroblasts induced vascular calcification
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism
Three-dimensional vascular microenvironment landscape in human glioblastoma
Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Disrupting concrete construction
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Vascular promotion reprograms the tumour microenvironment toward enhanced drug delivery
Vascular normalization: a strategy to recondition the tumor immune microenvironment
Vascular wall microenvironment: exosomes secreted by adventitial fibroblasts induced vascular calcification
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism
Three-dimensional vascular microenvironment landscape in human glioblastoma
Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Disrupting concrete construction
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Vascular promotion reprograms the tumour microenvironment toward enhanced drug delivery